Leveraging Permanent Capital & AI in Biotech Investing
Explores how permanent capital structures, time arbitrage, and AI-driven epistemic engines are reshaping biotech investment strategies. Analyzes market dynamics, regulatory impacts, and the shift toward proprietary system building for sustainable alpha generation.